Natixis Advisors LLC Increases Stake in Doximity, Inc. (NASDAQ:DOCS)

Natixis Advisors LLC lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 43.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 31,815 shares of the company’s stock after purchasing an additional 9,644 shares during the period. Natixis Advisors LLC’s holdings in Doximity were worth $1,386,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in DOCS. William Blair Investment Management LLC lifted its position in Doximity by 15.8% in the second quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after purchasing an additional 873,682 shares during the last quarter. Clearbridge Investments LLC raised its holdings in Doximity by 7.1% during the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after buying an additional 387,200 shares during the last quarter. Swedbank AB purchased a new stake in Doximity during the 1st quarter valued at $91,673,000. Janus Henderson Group PLC grew its holdings in Doximity by 33.5% in the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after acquiring an additional 621,590 shares during the last quarter. Finally, Renaissance Technologies LLC grew its holdings in Doximity by 23.1% in the 2nd quarter. Renaissance Technologies LLC now owns 1,603,202 shares of the company’s stock worth $44,842,000 after acquiring an additional 301,100 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $53.54 on Wednesday. The company has a 50 day simple moving average of $44.83 and a two-hundred day simple moving average of $35.34. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The company has a market capitalization of $10.00 billion, a price-to-earnings ratio of 61.53, a P/E/G ratio of 3.91 and a beta of 1.30.

Analysts Set New Price Targets

DOCS has been the subject of a number of analyst reports. Evercore ISI increased their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Canaccord Genuity Group cut Doximity from a “buy” rating to a “hold” rating and increased their price objective for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. The Goldman Sachs Group started coverage on Doximity in a research report on Friday, November 15th. They issued a “neutral” rating and a $58.00 price objective on the stock. Raymond James restated an “outperform” rating and set a $65.00 target price (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Finally, Bank of America lifted their price target on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Eleven analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $52.27.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.